Published in Neurol Sci on May 09, 2012
Evidence against the involvement of chronic cerebrospinal venous abnormalities in multiple sclerosis. A case-control study. PLoS One (2013) 1.04
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis. BMC Med (2013) 0.94
Potential involvement of the extracranial venous system in central nervous system disorders and aging. BMC Med (2013) 0.91
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development. Mult Scler Int (2013) 0.88
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurol Sci (2013) 0.85
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants. BMC Med (2013) 0.84
A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg (2009) 7.58
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med (1996) 6.90
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2008) 5.35
Venous angioplasty in patients with multiple sclerosis: results of a pilot study. Eur J Vasc Endovasc Surg (2011) 4.68
No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol (2010) 4.31
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med (1996) 3.63
No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol (2011) 3.07
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol (2008) 2.65
Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler (2010) 2.54
The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med (2006) 2.42
The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med (2007) 2.16
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
The rise of people power. Nature (2011) 1.99
Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol (2008) 1.98
The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry (2011) 1.96
Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke (2002) 1.81
Postural dependency of the cerebral venous outflow. Lancet (2000) 1.81
Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab (2009) 1.80
Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci (1989) 1.78
Duplex ultrasonography for assessment of venous valvular function of the lower limb. Br J Surg (1994) 1.76
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain (2003) 1.75
Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med (1982) 1.75
Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology (2004) 1.72
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry (1988) 1.69
No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry (2010) 1.68
Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol (2010) 1.66
Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol (2010) 1.66
Complications in MS patients after CCSVI procedures abroad (Calgary, AB). Can J Neurol Sci (2011) 1.62
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54
Stress failure in pulmonary capillaries. J Appl Physiol (1985) (1991) 1.52
Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol (1994) 1.46
["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients]. Nervenarzt (2010) 1.45
CCSVI and MS: a never-ending story. Eur J Vasc Endovasc Surg (2011) 1.43
The Internal jugular veins are asymmetric. Usefulness of ultrasound before catheterization. Intensive Care Med (2001) 1.39
Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses (1986) 1.32
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol (2011) 1.30
Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol (2005) 1.27
The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci (2004) 1.25
Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res (2010) 1.25
Extracranial venous hemodynamics in multiple sclerosis: a case-control study. Neurology (2011) 1.24
Fibrin mechanisms and functions in nervous system pathology. Mol Interv (2004) 1.22
Neurodegeneration with brain iron accumulation - clinical syndromes and neuroimaging. Biochim Biophys Acta (2011) 1.20
Functional and morphological criteria of internal jugular valve insufficiency as assessed by ultrasound. J Neuroimaging (2005) 1.20
Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage (2006) 1.19
Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol (2011) 1.19
Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology (2010) 1.18
Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Ann Neurol (2010) 1.16
Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology (2011) 1.14
Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg (1989) 1.11
Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology (2010) 1.10
Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study. BMC Neurol (2011) 1.08
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler (2010) 1.07
The chronic cerebrospinal venous insufficiency syndrome. Phlebology (2010) 1.06
Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques. AJNR Am J Neuroradiol (2011) 1.02
MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging (2011) 1.01
Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol (2010) 1.00
The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99
Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course. Int Angiol (2010) 0.98
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging (2000) 0.97
Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin Pediatr Neurol (2006) 0.96
Venous drainage in multiple sclerosis: a combined MRI and ultrasound study. Neurology (2011) 0.96
Deep gray matter and fatigue in MS: a T1 relaxation time study. J Neurol (2006) 0.92
Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. AJR Am J Roentgenol (2009) 0.92
Internal jugular thrombosis post venoplasty for chronic cerebrospinal venous insufficiency. Phlebology (2011) 0.91
Iron deposits and multiple sclerosis. Arch Pathol Lab Med (1984) 0.91
An endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients - 6 month follow-up results. Neuro Endocrinol Lett (2011) 0.90
Extra-cranial venous flow in patients with multiple sclerosis. J Neurol Sci (2011) 0.90
Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis. J Vasc Interv Radiol (2011) 0.88
Results of treatment of multiple sclerosis with dicoumarin. Arch Neurol Psychiatry (1947) 0.87
Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci (2011) 0.85
Twenty years of metallo-neurobiology: where to now? Eur Biophys J (2007) 0.82
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice. PLoS One (2012) 0.81
Assessment of intracranial venous hemodynamics in normal individuals and patients with cerebral venous thrombosis. Stroke (1999) 0.81
Interventional endovascular management of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a position statement by the Society of Interventional Radiology, endorsed by the Canadian Interventional Radiology Association. J Vasc Interv Radiol (2010) 0.80
[Evaluation of blood flow and the cross-sectional area of internal jugular vein in Japanese multiple sclerosis and neuromyelitis optica patients]. Rinsho Shinkeigaku (2011) 0.80
Intracranial venous pressure is normal in patients with multiple sclerosis. Mult Scler (2011) 0.78
Multiple sclerosis and the accumulation of iron in the Basal Ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol (2010) 0.77
Blood flow velocities in the vertebral veins of healthy subjects: a duplex sonographic study. J Neuroimaging (1999) 0.77
The treatment of multiple sclerosis in Los Angeles and the United States, 1947-1960. Bull Hist Med (2003) 0.75
Newer Conceptions of Postinfectious and Related Forms of Encephalitis. Bull N Y Acad Med (1941) 0.75
[Dicumarol therapy of disseminated sclerosis]. Ugeskr Laeger (1952) 0.75
Recent advances in research and treatment of multiple sclerosis. Ohio Med (1949) 0.75
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol (2011) 3.07
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol (2009) 2.20
Jugular veins in transient global amnesia: innocent bystanders. Stroke (2012) 2.19
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol (2007) 2.07
Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol (2007) 1.51
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol (2008) 1.48
Cortical lesions in multiple sclerosis. Nat Rev Neurol (2010) 1.47
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol (2010) 1.46
Severe relapses under fingolimod treatment prescribed after natalizumab. Neurology (2012) 1.40
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol (2004) 1.38
Cortical lesion load associates with progression of disability in multiple sclerosis. Brain (2012) 1.26
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res (2008) 1.26
MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet (2009) 1.19
Cortical pathology and cognitive impairment in multiple sclerosis. Expert Rev Neurother (2011) 1.10
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem (2009) 1.09
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Brain (2006) 1.09
No MRI evidence of cortical lesions in neuromyelitis optica. Neurology (2012) 1.08
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler (2010) 1.07
Immunogenicity of interferon beta: differences among products. J Neurol (2004) 1.05
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol (2008) 1.03
The clinical impact of interferon beta antibodies in relapsing-remitting MS. J Neurol (2004) 1.00
Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. Neuroimage (2008) 0.99
The safety profile of cyclophosphamide in multiple sclerosis therapy. Expert Opin Drug Saf (2007) 0.97
Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J Neurol Neurosurg Psychiatry (2009) 0.93
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. Radiology (2011) 0.93
A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Circ Arrhythm Electrophysiol (2013) 0.91
Anatomical correlates of cognitive functions in early Parkinson's disease patients. PLoS One (2013) 0.90
Low degree of cortical pathology is associated with benign course of multiple sclerosis. Mult Scler (2012) 0.89
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. PLoS One (2011) 0.89
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study. J Cereb Blood Flow Metab (2012) 0.89
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study. J Neurol Neurosurg Psychiatry (2010) 0.88
Cyclophosphamide-based combination therapies for autoimmunity. Neurol Sci (2008) 0.86
Acute disseminated encephalomyelitis in children: focus on relapsing patients. Pediatr Neurol (2008) 0.85
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge. World J Gastroenterol (2011) 0.85
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurol Sci (2009) 0.84
Neurofunctional modulation of brain regions by the observation of pointing and grasping actions. Cereb Cortex (2008) 0.84
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Mult Scler (2011) 0.83
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.83
The changing clinical course of multiple sclerosis: a matter of gray matter. Ann Neurol (2013) 0.83
Grey matter lesions in MS: from histology to clinical implications. Prion (2012) 0.81
The puzzle of multiple sclerosis: gray matter finds its place. Expert Rev Neurother (2011) 0.81
Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy. J Neurol (2006) 0.81
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study. Mult Scler (2010) 0.80
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis: a comparative study. J Neurol (2006) 0.80
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology (2011) 0.79
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci (2013) 0.79
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection. J Interferon Cytokine Res (2010) 0.78
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination. BMC Gastroenterol (2014) 0.77
Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death. J Cardiovasc Med (Hagerstown) (2013) 0.77
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis. J Neurol (2003) 0.77
In situ electrostimulation drives a regenerative shift in the zone of infarcted myocardium. Cell Transplant (2012) 0.77
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. Mult Scler Int (2012) 0.76
Investigation of the neural correlates underlying action observation in multiple sclerosis patients. Exp Neurol (2009) 0.76
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience. Expert Rev Anticancer Ther (2015) 0.76
The MBP-reactive repertoire is shaped by recognition of minor histocompatibility antigens. J Neuroimmunol (2004) 0.75
Evaluation of myocardial functional parameters during intravenous cyclophosphamide pulse therapy: a case report. Mult Scler (2002) 0.75
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood'. Aging Clin Exp Res (2012) 0.75
Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure. Ital Heart J (2005) 0.75
Echo-color Doppler diagnosis of an unusual cause of neck mass. Echocardiography (2004) 0.75
Hepatocellular Carcinoma in Alcoholic Liver Disease: Current Management and Recent Advances. Rev Recent Clin Trials (2016) 0.75
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations. Am J Med Sci (2011) 0.75
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health. New Microbiol (2015) 0.75
Inducibility of ventricular arrhythmia and tachyarrhythmia recurrences in patients with implantable defibrillator. Hellenic J Cardiol (2015) 0.75